TGDVX | VIVIX | TGDVX / VIVIX | |
Total Expense Ratio | 0.85 | 0.04 | 2,125% |
Annual Report Gross Expense Ratio | 1.05 | 0.04 | 2,625% |
Fund Existence | 27 years | 27 years | - |
Gain YTD | 1.745 | 2.452 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 444M | 189B | 0% |
Annual Yield % from dividends | 0.77 | 2.29 | 34% |
Returns for 1 year | 4.13 | 8.01 | 52% |
Returns for 3 years | 33.12 | 32.19 | 103% |
Returns for 5 years | 62.65 | 72.56 | 86% |
Returns for 10 years | -26.07 | 103.54 | -25% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THISX | 77.36 | -0.37 | -0.48% |
T. Rowe Price Health Sciences I | |||
RGSCX | 23.70 | -0.30 | -1.25% |
Virtus KAR Global Small-Cap C | |||
FAMEX | 58.61 | -0.76 | -1.28% |
FAM Dividend Focus Fund Investor | |||
WEGRX | 12.11 | -0.16 | -1.30% |
Allspring Emerging Growth R6 | |||
BBTIX | 12.73 | -0.20 | -1.55% |
Bridge Builder Tax Managed Intl Eq |